Syntr Health Technologies, Inc.

Syntr Health Technologies manufactures automated microfat processing systems for cosmetic and reconstructive applications. The company's flagship product, the SyntrFuge System, is an FDA-cleared device that automates the harvesting, processing, and preparation of autologous adipose tissue (fat) for transfer and injection. The system uses proprietary AdipoChambers and AdipoSets technology to create microfat with high cell viability in a minimally invasive, repeatable manner. The SyntrFPU 360 is a complementary accessory device that spins AdipoSets to facilitate consistent microsizing of adipose tissue. Syntr's technology eliminates the need for operating room procedures, reduces variability in output quality, and enables practitioners to offer natural, patient-derived rejuvenation treatments without synthetic chemicals or enzymes. Current applications target aesthetics and plastic surgery markets, with future therapeutic applications under development. The company holds US and international patents and has achieved FDA clearance. Syntr operates a partner network model, recruiting and training clinical practitioners to offer microfat treatments through its systems.